Chris Bolinger

Chris Bolinger is a seasoned professional in intellectual property and trademarks, currently serving as Senior Director of IP Development & Commercial and Head of Global Trademarks at Astellas Pharma since 2020. Prior experience includes roles as Senior Intellectual Property Counsel at Wolverine Worldwide, Director and Counsel for Trademarks & Copyrights at Merck, and Counsel at ConvaTec, Bristol-Myers Squibb, and Pfizer. Bolinger began a legal career as an Associate at Brinks Hofer Gilson and Lione and Thompson Coburn LLP. Educational qualifications include a BA in Psychology from Columbia College, Columbia University, a JD from Georgetown University Law Center, and a Diploma Programme from the International Baccalaureate.